Total net assets ($CAD):
$189.58 million

The top 15 holdings make up 70.71% of the Fund.
US Equity
International Equity
Cash and Equivalents
Canadian Equity
Other
United States
Japan
Germany
United Kingdom
France
Canada
Switzerland
Singapore
Brazil
Other
Healthcare
Consumer Services
Financial Services
Cash and Cash Equivalent
Real Estate
Other
Top holdings Sector allocation (%)
Alexion Pharmaceuticals Inc Drugs 6.10%
Takeda Pharmaceutical Co Ltd Drugs 5.95%
Bristol-Myers Squibb Co Drugs 5.86%
Merit Medical Systems Inc Drugs 5.69%
Intercept Pharmaceuticals Inc Drugs 5.45%
Biogen Idec Inc Drugs 5.35%
CVS Health Corp Retail 5.24%
SeaSpine Holdings Corp Diversified Healthcare 4.85%
Ionis Pharmaceuticals Inc Drugs 4.73%
Fresenius Medical Care AG & Co KGaA Healthcare Services 4.27%
Astellas Pharma Inc Drugs 4.26%
GlaxoSmithKline PLC Drugs 3.45%
Sangamo BioSciences Inc Diversified Healthcare 3.38%
Trupanion Inc Insurance 3.31%
Sanofi SA Drugs 2.82%
Asset allocation

US Equity 64.83%

International Equity 31.43%

Cash and Equivalents 2.03%

Canadian Equity 1.69%

Other 0.02%

Geographic allocation

United States 65.78%

Japan 13.02%

Germany 6.69%

United Kingdom 3.45%

France 2.82%

Canada 2.77%

Switzerland 2.19%

Singapore 1.30%

Brazil 1.07%

Other 0.91%

Sector allocation

Healthcare 83.51%

Consumer Services 8.05%

Financial Services 5.32%

Cash and Cash Equivalent 2.03%

Real Estate 1.07%

Other 0.02%